Caution needed for full correction in low astigmatism

Article

Caution should be used when considering full astigmatic correction for manifest cylinder of 0.5 D or less in myopic patients, according to the latest investigation in the Journal of Cataract and Refractive Surgery.

Caution should be used when considering full astigmatic correction for manifest cylinder of 0.5 D or less in myopic patients, according to the latest investigation in the Journal of Cataract and Refractive Surgery.

The retrospective cross-sectional data analysis, headed by Dr Andreas Frings, Department of Ophthalmology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany, enrolled 448 eyes of 448 myopic patients with low astigmatism of 0.75 D or less.

The preoperative and postoperative outcome measures were manifest refraction spherical equivalent (MRSE), uncorrected distance visual acuity (UDVA) and corrected distance visual acuity. Astigmatic changes were recorded using the Alpins vector analysis.

Four months postoperatively the mean UDVA was 0.10 ± 0.13 logMAR and the mean MRSE was −0.05 ± 0.68 D. The preoperative groups demonstrated no significant differences in efficacy or safety.

The correction index, the magnitude of error, the index of success and the flattening index suggested astigmatic overcorrection for a preoperative cylinder of 0.25 D and 0.50 D.

To read the abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.